Siyu Xing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Siyu Xing has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Chunhong Zhang
Institute of Food Science and Technology Ministry of Agriculture and Rural Affairs Chinese Academy of Agricultural Sciences Key Laboratory of Agro-products Processing 100193 Beijing China
1 shared publication - Da Li
School of Biology and Medicine, Beijing City University, Beijing 100094, China
1 shared publication - Dan Li
School of Biology and Medicine Beijing City University 100094 Beijing China
1 shared publication - Dong Liang
Translational Medicine Research Center Naval Medical University 200433 Shanghai China
1 shared publication - Fengzhong Wang
Key Laboratory of Agro-Products Processing, Ministry of Agriculture and Rural Affairs, Key Laboratory of Agro-products Quality and Safety Control in Storage and Transport Process, Ministry of Agriculture and Rural Affairs, Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Beijing 100193, PR China
1 shared publication - Tianqi Chen
Institute of Food Science and Technology Ministry of Agriculture and Rural Affairs Chinese Academy of Agricultural Sciences Key Laboratory of Agro-products Processing 100193 Beijing China
1 shared publication
Latest Publications
- Open Access
- 26 December 2025
- Published by IMR Press in International Journal for Vitamin and Nutrition Research
- Vol. 95 (6) , 42590
Discriminative Gut Microbial Signatures in Hyperuricemia and Overweight Populations Revealed by Metagenomic Sequencing
Background: This cross-sectional study aimed to investigate the relationships between gut microbiota compositional alterations and chronic metabolic disorders by analyzing taxonomic diversity, community structure, and species-level differences in individuals with hyperuricemia (HUA) and a history of being overweight. Our findings offer novel insights into microbiota-targeted therapeutic strategies for managing metabolic diseases. A total of 144 participants were recruited and divided into three diagnostic categories: healthy controls (HL, n = 29), hyperuricemia group (HU, n = 24), and overweight (OW, n = 91). Methods: Comprehensive phenotypic profiles and metagenomes were analyzed for fecal samples from the three groups. Results: Significant differences were observed in psychological states and microbial ecology between the metabolic disorder groups (HU and OW) and the control group (HL) (p < 0.05). Both the overweight individuals and those with HUA presented significant changes in gut microbial composition, with reduced α-diversity indices (Shannon index: HU vs HL Mann–Whitney U = 306; p = 0.462; OW vs HL Mann–Whitney U = 1008; p = 0.040; richness index: HU vs HL Mann–Whitney U = 307; p = 0.469; OW vs HL Mann–Whitney U = 1072; p = 0.092) compared to healthy individuals. Moreover, analysis of the linear discriminant analysis effect size (LEfSe) identified four discriminatory species in the HU group (Alistipes putredinis, Mediterraneibacter faecis, Streptococcus oralis, and Gemella sanguinis), and five in the OW group (Pantoea endophytica, Pantoea vagans, Phocaeicola coprophilus, Ruminococcus SGB4421, and Klebsiella oxytoca), representing potential biomarkers for the progression of chronic metabolic diseases. Conclusion: This study elucidates the characteristics of overweight individuals and those with HUA in terms of phenotypic features and gut microbiota, providing a theoretical reference for gut microbiota-targeted therapies and lifestyle interventions in chronic metabolic diseases.
- 26 December 2025
- Published by IMR Press in International Journal for Vitamin and Nutrition Research
- Vol. 95 (6) , 42590
Open AccessDiscriminative Gut Microbial Signatures in Hyperuricemia and Overweight Populations Revealed by Metagenomic Sequencing
Background: This cross-sectional study aimed to investigate the relationships between gut microbiota compositional alterations and chronic metabolic disorders by analyzing taxonomic diversity, community structure, and species-level differences in individuals with hyperuricemia (HUA) and a history of being overweight. Our findings offer novel insights into microbiota-targeted therapeutic strategies for managing metabolic diseases. A total of 144 participants were recruited and divided into three diagnostic categories: healthy controls (HL, n = 29), hyperuricemia group (HU, n = 24), and overweight (OW, n = 91). Methods: Comprehensive phenotypic profiles and metagenomes were analyzed for fecal samples from the three groups. Results: Significant differences were observed in psychological states and microbial ecology between the metabolic disorder groups (HU and OW) and the control group (HL) (p < 0.05). Both the overweight individuals and those with HUA presented significant changes in gut microbial composition, with reduced α-diversity indices (Shannon index: HU vs HL Mann–Whitney U = 306; p = 0.462; OW vs HL Mann–Whitney U = 1008; p = 0.040; richness index: HU vs HL Mann–Whitney U = 307; p = 0.469; OW vs HL Mann–Whitney U = 1072; p = 0.092) compared to healthy individuals. Moreover, analysis of the linear discriminant analysis effect size (LEfSe) identified four discriminatory species in the HU group (Alistipes putredinis, Mediterraneibacter faecis, Streptococcus oralis, and Gemella sanguinis), and five in the OW group (Pantoea endophytica, Pantoea vagans, Phocaeicola coprophilus, Ruminococcus SGB4421, and Klebsiella oxytoca), representing potential biomarkers for the progression of chronic metabolic diseases. Conclusion: This study elucidates the characteristics of overweight individuals and those with HUA in terms of phenotypic features and gut microbiota, providing a theoretical reference for gut microbiota-targeted therapies and lifestyle interventions in chronic metabolic diseases.